HP4 DRUG COSTS DEVELOPMENT AFTER PATENT EXPIRY IN THE THE NETHERLANDS
Nov 1, 2004, 00:00
10.1016/S1098-3015(10)65681-1
https://www.valueinhealthjournal.com/article/S1098-3015(10)65681-1/fulltext
Title :
HP4 DRUG COSTS DEVELOPMENT AFTER PATENT EXPIRY IN THE THE NETHERLANDS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)65681-1&doi=10.1016/S1098-3015(10)65681-1
First page :
Section Title :
Open access? :
No
Section Order :
50